22nd Century Group has sold GVB Biopharma to Specialty Acquisition Corporation

Client: 22nd Century Group

Client Location: United States

Target: GVB Biopharma

Target Location: United States

Acquirer: Speciality Acquisition Corporation

Acquirer Location: United States

Target Description: GVB grows, manufactures and processes hemp cannabinoid products.

22nd Century Group GVB Biopharma Specialty Acquisition Corporation 2023 Connect with a Senior Team Member

Meet our Senior Team

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.